The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Increasing use of gonadotropin‐releasing hormone agonists for the treatment of localized prostate carcinoma
Abstract
BACKGROUND: The role of androgen deprivation therapy in prostate carcinoma is controversial in earlier stages of disease. The authors examined the time trends and patterns of use for androgen deprivation in the form of gonadotropin‐releasing hormone (GnRH) agonists or orchiectomy, in population‐based tumor registries. METHODS: Data were obtained from the linked Surveillance, Epidemiology and End Results‐Medicare database. A total of 100,274 men with prostate carcinoma diagnosed from 1991 through 1999 were selected. The main outcome was the proportion of men who received ≥ 1 dose of a GnRH agonist in the first 6 months of diagnosis. This was plotted by year and stratified for age, grade, stage as well as primary versus adjuvant usage. Multiple logistic regression was used to examine predictors of GnRH agonist use in the subset of patients with localized cancer. RESULTS: There was a consistent increase in GnRH agonist use by year for all ages, stages, and grades. Even in men ≥ 80 years with localized stage and low to moderate grade tumors, primary GnRH agonist use increased over the study period, from 3.7% in 1991 to 30.9% in 1999 (P < 0.001). The multivariable analysis showed that significant variability in GnRH agonist use existed among SEER geographic regions. CONCLUSIONS: The use of GnRH agonists for prostate carcinoma increased dramatically during the 1990s. This increase occurred across all stages and histologic grades of prostate carcinoma, and was greatest in patients ≥ 80 years. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Huggins, C., & Hodges, C. V. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64820-3 · Cited by 3,855
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Beahrs, O. H., & Henson, D. E. (1992) · Medical Entomology and Zoology · Cited by 2,460
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Development of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,845
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · PubMed · doi:10.1097/01.mlr.0000020942.47004.03 · Cited by 1,714
Bolla, M., Gonzalez, D., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Gil, T., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370502 · Cited by 1,548
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., & Goodman, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210702 · Cited by 1,464
Risk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Self-citationAmerican Joint Committee on Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88441-7 · Cited by 1,328
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · Medical Care · doi:10.1097/00005650-200208001-00002 · Cited by 772
Changes in body composition during androgen deprivation therapy for prostate cancer
Smith, M. R., Finkelstein, J. S., McGovern, F. J., Zietman, A. L., Fallon, M. A., Schoenfeld, D. A., & Kantoff, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8299 · Cited by 697
POTOSKY, A. L., RILEY, G. F., LUBITZ, J. D., MENTNECH, R. M., & KESSLER, L. G. (1993) · Medical Care · doi:10.1097/00005650-199308000-00006 · Cited by 694
(1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.d01-6840.x · Cited by 654
Pilepich, M. V., Caplan, R., Byhardt, R. W., Lawton, C. A., Gallagher, M. J., Mesic, J. B., Hanks, G. E., Coughlin, C. T., Porter, A., Shipley, W. U., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1013 · Cited by 607
Adib, R., Anderson, J., Ashken, M. H., Baumber, C. D., CRA, B. D., BEYNON, L. L., Blaxland, J. W., Boag, V., Bolger, J., Boreham, J., et al. (1997) · Kent Academic Repository (University of Kent) · Cited by 551
SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMY
Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I., & Walsh, P. C. (1993) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00924-1 · Cited by 460
Smith, J. C., Bennett, S., Evans, L. M., Kynaston, H. G., Parmar, M., Mason, M. D., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7851 · Cited by 458
Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-institutional Pooled Analysis
Shipley, W. U., Thames, H. D., Sandler, H. M., Hanks, G. E., Zietman, A. L., Perez, C. A., Kuban, D. A., Hancock, S. L., & Smith, C. D. (1999) · JAMA · doi:10.1001/jama.281.17.1598 · Cited by 440
SOLOWAY, M. S., PAREEK, K., SHARIFI, R., WAJSMAN, Z., McLEOD, D., WOOD, D. P., PURAS-BAEZ, A., & THE LUPRON DEPOT NEOADJUVANT PROSTATE CANCER STUDY GROUP† (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65393-1 · Cited by 341
National Practice Patterns and Time Trends in Androgen Ablation for Localized Prostate Cancer
Cooperberg, M. R., Grossfeld, G. D., Lubeck, D. P., & Carroll, P. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.981 · Cited by 329
Physicians?? Reactions to Uncertainty in Patient Care A New Measure and New Insights
Gerrity, M. S., DeVellis, R. F., & Earp, J. A. (1990) · Medical Care · doi:10.1097/00005650-199008000-00005 · Cited by 314
Studying Radiation Therapy Using SEER-Medicare-Linked Data
Virnig, B. A., Warren, J. L., Cooper, G. S., Klabunde, C. N., Schussler, N., & Freeman, J. (2002) · Medical Care · doi:10.1097/00005650-200208001-00007 · Cited by 286
Self-citationEstimating Treatment Benefits for the Elderly: The Effect of Competing Risks
Welch, H. G., Albertsen, P. C., Nease, R. F., Bubolz, T. A., & Wasson, J. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-6-199603150-00007 · Cited by 281
The capsure database: a methodology for clinical practice and research in prostate cancer
Lubeck, D. P., Litwin, M. S., Henning, J. M., Stier, D. M., Mazonson, P., Fisk, R., Carroll, P. R., & panel, T. C. R. (1996) · Urology · doi:10.1016/s0090-4295(96)00226-9 · Cited by 268
Middleton, R. G., Thompson, I. M., Austenfeld, M. S., Cooner, W. H., Correa, R. J., Gibbons, R. P., Miller, H. C., Oesterling, J. E., Resnick, M. I., & Smalley, S. R. (1995) · PubMed · Cited by 261
Potosky, A. L., Knopf, K., Clegg, L. X., Albertsen, P. C., Stanford, J. L., Hamilton, A. S., Gilliland, F. D., Eley, J. W., Stephenson, R. A., & Hoffman, R. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.17.3750 · Cited by 251
Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
Higano, C. S. (2003) · Urology · doi:10.1016/s0090-4295(02)02397-x · Cited by 238
GRANFORS, T., MODIG, H., DAMBER, J.-E., & TOMIC, R. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63235-x · Cited by 218
Middleton, R. G., Thompson, I. M., Austenfeld, M. S., Cooner, W. H., Correa, R. J., Gibbons, R. P., Miller, H. C., Oesterling, J. E., Resnick, M. I., Smalley, S. R., et al. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)66718-1 · Cited by 214
Harlan, L. C., Potosky, A., Gilliland, F. D., Hoffman, R., Albertsen, P. C., Hamilton, A. S., Eley, J. W., Stanford, J. L., & Stephenson, R. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1864 · Cited by 192
Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer
Meng, M. V., Grossfeld, G. D., Sadetsky, N., Mehta, S. S., Lubeck, D. P., & Carroll, P. R. (2002) · Urology · doi:10.1016/s0090-4295(02)01560-1 · Cited by 156
Agreement of Medicare Claims and Tumor Registry Data for Assessment of Cancer-Related Treatment
Cooper, G. S., Yuan, Ž., Stange, K. C., Dennis, L. K., Amini, S. B., & Rimm, A. A. (2000) · Medical Care · doi:10.1097/00005650-200004000-00008 · Cited by 124
Physicians' current procedural terminology : CPT 95
Kirschner, C. G. (1994) · American Medical Association eBooks · Cited by 121
Fowler, F. J., COLLINS, M. M., Corkery, E. W., Elliott, D. B., & Barry, M. J. (2002) · Cancer · doi:10.1002/cncr.10656 · Cited by 110
Walsh, P. C., DeWeese, T. L., & Eisenberger, M. A. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65972-1 · Cited by 110
Parry, D. M., Goldsmith, A. R., Millar, R. P., & Glennie, L. M. (1997) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1997.00575.x · Cited by 107
Etzioni, R., Berry, K., Legler, J. M., et al. (2002) · Urology · doi:10.1016/s0090-4295(01)01516-3 · Cited by 105
Critical evaluation of hormonal therapy for carcinoma of the prostate
Chodak, G. W., Keane, T. E., & Klotz, L. H. (2002) · Urology · doi:10.1016/s0090-4295(02)01677-1 · Cited by 87
Practice Trends in the Diagnosis and Management of Prostate Cancer in the United States
Gee, W. F., Holtgrewe, H. L., Albertsen, P. C., et al. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67270-7 · Cited by 63
Wasson, J. H., Fowler, F. J., & Barry, M. J. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63223-3 · Cited by 39
THE COST VALUE OF MEDICAL VERSUS SURGICAL HORMONAL THERAPY FOR METASTATIC PROSTATE CANCER
Chon, J. K., Jacobs, S. C., & Naslund, M. J. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67292-8 · Cited by 33
COLLINS, M. M., Barry, M. J., Zietman, A. L., Albertsen, P. C., Talcott, J. A., Corkery, E. W., Elliott, D. B., & Fowler, F. J. (2002) · Urology · doi:10.1016/s0090-4295(02)01832-0 · Cited by 23
Hormonal therapy for prostate cancer: primum non nocere
MILBANK, A. J., Dreicer, R., & Klein, E. A. (2002) · Urology · doi:10.1016/s0090-4295(02)01867-8 · Cited by 13
A decision analysis of alternative treatment strategies for clinically localized prostate cancer
Fleming, C. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500200064035 · Cited by 4
Cited by
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455
Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., & Newton, R. U. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2488 · Cited by 657
Keating, N. L., O'Malley, A. J., Freedland, S. J., & Smith, M. R. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp404 · Cited by 622
Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality
Tsai, H. K., D'Amico, A. V., Sadetsky, N., Chen, M.-H., & Carroll, P. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm168 · Cited by 520
Metadata
- Authors
- Shahinian, V. B., Kuo, Y., Freeman, J. L., Orihuela, E., & Goodwin, J. S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-03
- Volume
- 103
- Issue
- 8
- Pages
- 1615-1624
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2013136992
- Cited by
- 323
- References
- 49
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.